Muhlenkamp & Company
Latest statistics and disclosures from Muhlenkamp & Co's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RUSHA, MCHP, DOW, MCK, MTZ, and represent 25.14% of Muhlenkamp & Co's stock portfolio.
- Added to shares of these 10 stocks: WCC (+$10M), BIDU (+$5.8M), RUSHA (+$5.2M), KEX, SLB, FNV, RGLD, TEN, CTSH, RUSHB.
- Started 5 new stock positions in WCC, RGLD, BIDU, FNV, SLB.
- Reduced shares in these 5 stocks: GLD, , MCHP, PFE, Rts/bristol-myers Squibb Compa.
- Sold out of its positions in Golar Lng Partners Lp unit.
- Muhlenkamp & Co was a net buyer of stock by $31M.
- Muhlenkamp & Co has $249M in assets under management (AUM), dropping by 28.68%.
- Central Index Key (CIK): 0001133219
Tip: Access up to 7 years of quarterly data
Positions held by Muhlenkamp & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Muhlenkamp & Co
Companies in the Muhlenkamp & Co portfolio as of the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Rush Enterprises Cl A (RUSHA) | 5.3 | $13M | +64% | 317k | 41.42 | |
| Microchip Technology (MCHP) | 5.3 | $13M | 95k | 138.11 | ||
| Dow (DOW) | 5.0 | $13M | 225k | 55.50 | ||
| McKesson Corporation (MCK) | 5.0 | $12M | 71k | 173.92 | ||
| MasTec (MTZ) | 4.6 | $11M | 167k | 68.18 | ||
| Broadcom (AVGO) | 4.3 | $11M | 24k | 437.86 | ||
| Apple (AAPL) | 4.2 | $11M | 80k | 132.68 | ||
| WESCO International (WCC) | 4.1 | $10M | NEW | 131k | 78.50 | |
| Microsoft Corporation (MSFT) | 4.0 | $9.9M | 45k | 222.42 | ||
| Meritage Homes Corporation (MTH) | 4.0 | $9.8M | 119k | 82.82 | ||
| Alliance Data Systems Corporation (ADS) | 3.7 | $9.3M | 125k | 74.10 | ||
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 3.4 | $8.6M | 37k | 231.86 | ||
| UnitedHealth (UNH) | 3.4 | $8.5M | 24k | 350.69 | ||
| Kirby Corporation (KEX) | 3.4 | $8.5M | +90% | 165k | 51.83 | |
| Spdr Gold Tr Gold Shs (GLD) | 3.4 | $8.5M | -31% | 48k | 178.37 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.4 | $8.3M | 51k | 165.04 | ||
| Bristol Myers Squibb (BMY) | 3.1 | $7.8M | 125k | 62.03 | ||
| Nmi Hldgs Cl A (NMIH) | 3.0 | $7.5M | 329k | 22.65 | ||
| CVS Caremark Corporation (CVS) | 3.0 | $7.4M | 108k | 68.30 | ||
| Lennar Corp Cl A (LEN) | 2.9 | $7.1M | 93k | 76.23 | ||
| Lockheed Martin Corporation (LMT) | 2.7 | $6.8M | 19k | 354.99 | ||
| Alps Etf Tr Alerian Mlp (AMLP) | 2.7 | $6.6M | 258k | 25.66 | ||
| Tenneco Cl A Vtg Com Stk (TEN) | 2.5 | $6.1M | 575k | 10.60 | ||
| Baidu Spon Adr Rep A (BIDU) | 2.4 | $5.8M | NEW | 27k | 216.25 | |
| Cameco Corporation (CCJ) | 2.1 | $5.2M | 385k | 13.40 | ||
| Biogen Idec (BIIB) | 1.8 | $4.4M | 18k | 244.83 | ||
| Wabtec Corporation (WAB) | 1.6 | $4.0M | 55k | 73.19 | ||
| Schlumberger (SLB) | 1.6 | $3.9M | NEW | 179k | 21.83 | |
| Gilead Sciences (GILD) | 1.2 | $3.0M | 51k | 58.26 | ||
| Franco-Nevada Corporation (FNV) | 0.9 | $2.2M | NEW | 17k | 125.35 | |
| Royal Gold (RGLD) | 0.9 | $2.1M | NEW | 20k | 106.35 | |
| Pfizer (PFE) | 0.4 | $874k | 24k | 36.82 | ||
| Morgan Stanley Com New (MS) | 0.3 | $740k | 11k | 68.49 | ||
| Cognizant Technology Solutio Cl A (CTSH) | 0.3 | $737k | +12% | 9.0k | 81.91 | |
| Enterprise Products Partners (EPD) | 0.2 | $487k | 25k | 19.59 | ||
| Rush Enterprises CL B (RUSHB) | 0.1 | $254k | +45% | 6.7k | 37.94 | |
| Bristol-myers Squibb Right 99/99/9999 | 0.0 | $48k | 69k | 0.69 |
Past Filings by Muhlenkamp & Co
SEC 13F filings are viewable for Muhlenkamp & Co going back to 1999
- Muhlenkamp & Co 2020 Q4 filed Feb. 11, 2021
- Muhlenkamp & Co 2020 Q3 filed Nov. 13, 2020
- Muhlenkamp & Co 2020 Q2 filed Aug. 20, 2020
- Muhlenkamp & Co 2019 Q4 filed Feb. 20, 2020
- Muhlenkamp & Co 2019 Q3 filed Nov. 27, 2019
- Muhlenkamp & Co 2019 Q2 filed Aug. 28, 2019
- Muhlenkamp & Co 2019 Q1 filed May 23, 2019
- Muhlenkamp & Co 2018 Q3 filed Nov. 13, 2018
- Muhlenkamp & Co 2018 Q2 filed Aug. 13, 2018
- Muhlenkamp & Co 2018 Q1 filed May 11, 2018
- Muhlenkamp & Co 2017 Q4 filed Feb. 14, 2018
- Muhlenkamp & Co 2017 Q3 filed Nov. 13, 2017
- Muhlenkamp & Co 2017 Q2 filed Aug. 11, 2017
- Muhlenkamp & Co 2017 Q1 restated filed May 17, 2017
- Muhlenkamp & Co 2017 Q1 filed May 11, 2017
- Muhlenkamp & Co 2016 Q4 filed Feb. 9, 2017